| Literature DB >> 17170447 |
Dupeh R Palmer1, Stefan Fernandez, John Bisbing, Kristina K Peachman, Mangala Rao, Dave Barvir, Vicky Gunther, Timothy Burgess, Yukari Kohno, R Padmanabhan, Wellington Sun.
Abstract
The yellow fever virus attenuated 17D vaccine strain is a safe and effective vaccine and a valuable model system for evaluating immune responses against attenuated viral variants. This study compared the in vitro interactions of the commercially available yellow fever vaccine (YF-VAX), Dengue virus and the live-attenuated dengue vaccine PDK50 with dendritic cells (DCs), the main antigen-presenting cells at the initiation of immune responses. Similar to PDK50, infection with YF-VAX generated activated DCs; however, for YF-VAX, activation occurred with limited intracellular virus replication. The majority of internalized virus co-localized with endolysosomal markers within 90 min, suggesting that YF-VAX is processed rapidly in DCs. These results indicate that restricted virus replication and lysosomal compartmentalization may be important contributing factors to the success of the YF-VAX vaccine.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17170447 DOI: 10.1099/vir.0.82272-0
Source DB: PubMed Journal: J Gen Virol ISSN: 0022-1317 Impact factor: 3.891